Evaluating eligibility criteria of oncology trials using real-world data and AI | Nature
LENVIMA® (lenvatinib) HCP Website | Overall Survival (OS)
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
Prioritizing Patient Preferences for Ovarian Cancer Treatment | Duke Health Referring Physicians
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Drug Trials Snapshot: LONSURF | FDA
Bavencio HCP UC Efficacy
LENVIMA® (lenvatinib) HCP Website | Overall Survival (OS)
Survival (time to event) Outcomes | Health Knowledge
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Study outcome measures examining efficacy of intervention | Download Table
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer - Clinical Lung Cancer
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer | NEJM
Articles Archives - Page 2 of 10 - GNS
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Checkmate 9LA 1L NSCLC Efficacy Data | OPDIVO® (nivolumab) + YERVOY® (ipilimumab)
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis | Prostate Cancer and Prostatic Diseases
Overexpression of H-Ryk in Epithelial Ovarian Cancer: Prognostic Significance of Receptor Expression | Clinical Cancer Research
Event-free and overall survival of all eligible patients on the study. | Download Scientific Diagram
Trial Outcome Measures | Download Table
Publications | Flatiron Health
LENVIMA® (lenvatinib) HCP Website | Clinical Study Design
Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer - Clinical Lung Cancer
Figure 3-2, Outcome Measures Framework - Tools and Technologies for Registry Interoperability, Registries for Evaluating Patient Outcomes: A User's Guide, 3rd Edition, Addendum 2 - NCBI Bookshelf
